Molecular Assemblies to Present at the 2017 BIO Investor Forum

Back

SAN DIEGO, CA. — Oct.13, 2017 — Molecular Assemblies Inc., a company developing a proprietary enzymatic DNA synthesis technology, today announced that President and CEO Michael J. Kamdar will present a corporate overview at the 2017 BIO Investor Forum being held in San Francisco Oct. 17-18 at the Westin St. Francis Hotel. The presentation will take place on Wednesday, Oct. 18 at 3:15 p.m. in presentation room Elizabethan B.

About Molecular Assemblies

Molecular Assemblies, Inc. is a San Diego-based company focused on developing an enzymatic DNA synthesis technology designed to power the next generation of DNA-based products. The company’s patented enzymatic method, based on making DNA the way nature makes DNA, produces long, high quality, sequence-specific DNA reliably, affordably and sustainably. Molecular Assemblies’ technology will enable the reading and writing of DNA for industries including industrial synthetic biology and precision medicine, as well as emerging applications of DNA for data information storage, nanomachines and bio-based electronics. For more information please visit molecularassemblies.com.

Contacts

Molecular Assemblies Media
Michael Kamdar, CEO
(858) 733-1308

Endpoint Communications
Susan Thomas
(619) 540-9195
susan@endpointcommunications.net